Edition:
United States

Erytech Pharma SA (ERYP.OQ)

ERYP.OQ on NASDAQ Stock Exchange Global Select Market

18.49USD
13 Dec 2017
Change (% chg)

$-0.07 (-0.38%)
Prev Close
$18.56
Open
$18.90
Day's High
$19.08
Day's Low
$18.49
Volume
14,165
Avg. Vol
--
52-wk High
$30.48
52-wk Low
$18.28

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 0.87 1.74 0.00 --
Quarter Ending Mar-18 1 1.57 1.57 1.57 --
Year Ending Dec-17 2 2.71 5.41 0.00 --
Year Ending Dec-18 2 9.53 19.07 0.00 --
Earnings (per share)
Quarter Ending Dec-17 2 -0.60 -0.58 -0.63 --
Quarter Ending Mar-18 1 -0.52 -0.52 -0.52 --
Year Ending Dec-17 3 -2.75 -2.64 -2.81 --
Year Ending Dec-18 3 -2.20 -1.60 -3.02 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) -- 100.67 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) -- 5.36 2.98
LT Debt to Equity (MRQ) -- 18.92 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -- -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -- -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -- -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,314,503 864,673,362
Net Income/Employee (TTM) -- 3,332,048 101,717,513
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) -- 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -- 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -- 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.32%
# of Holders: 1
Total Shares Held: 3,090,069
3 Mo. Net Change: 3,090,069
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.